These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6340858)

  • 21. [Urinary FDP D-dimer and E fragments in renal transplantation].
    Akiyama T; Ikegami M; Imanishi M; Ishii T; Nishioka T; Uemura T; Kunikata S; Mitsubayashi S; Kanda H; Matsuura T
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1680-5. PubMed ID: 2287115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease.
    Wellwood JM; Ellis BG; Price RG; Hammond K; Thompson AE; Jones NF
    Br Med J; 1975 Aug; 3(5980):408-11. PubMed ID: 1156788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced renal allograft survival is related to low urinary N-acetyl-beta-D-glucosaminidase excretion during the first posttransplant month.
    Kotanko P; Margreiter R; Pfaller W
    Transplantation; 1996 Feb; 61(3):388-92. PubMed ID: 8610347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of elevated urinary N-acetyl-beta-D-glucosaminidase activity in chronic cadmium poisoning.
    Nogawa K; Yamada Y; Kido T; Honda R; Ishizaki M; Tsuritani I; Kobayashi E
    Sci Total Environ; 1986 Sep; 53(3):173-8. PubMed ID: 3764409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excretion of urinary N-acetyl-beta-D-glucosaminidase isoenzymes after renal transplantation in the rat.
    Bourbouze R; Dubois M; Gluckman JC; Legrain M
    J Clin Chem Clin Biochem; 1987 Feb; 25(2):71-6. PubMed ID: 3553416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 5-year experience of N-acetyl-beta-glucosaminidase for diagnosis of rejection in renal transplantation.
    Corbett CR; Wellwood JM; Tucker SM; Thompson AE
    Transplant Proc; 1979 Jun; 11(2):1226. PubMed ID: 382491
    [No Abstract]   [Full Text] [Related]  

  • 27. N-Acetyl-beta-D-glucosaminidase in urine of patients with renal disease, and after renal transplants and surgery.
    Kind PR
    Clin Chim Acta; 1982 Feb; 119(1-2):89-97. PubMed ID: 7037232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporine nephrotoxicity and rejection crisis: diagnosis by urinary enzyme excretion.
    Bornstein B; Arenas J; Morales JM; Praga M; Rodicio JL; Martinez A; Valdivieso L
    Nephron; 1996; 72(3):402-6. PubMed ID: 8852487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
    Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation.
    Ekberg M; Bergentz SE; Hedner U; Nilsson IM
    Scand J Urol Nephrol; 1976; 10(1):56-62. PubMed ID: 775625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assay of N-acetyl-beta-D-glicosaminidase in urine of patients with renal transplants as an indicator of rejection.
    Thompson AE; Tucker SM; Price RG
    Clin Chem; 1977 Feb; 23(2 PT. 1):301-2. PubMed ID: 318944
    [No Abstract]   [Full Text] [Related]  

  • 32. Urinary enzyme excretion by renal-transplant recipients in relation to interval after transplantation.
    Jung K; Diego J; Scholz D; Schröder K; Strobelt V
    Clin Chem; 1982 Aug; 28(8):1762-4. PubMed ID: 6124328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary lysosomal enzymes for detection of acute renal allograft rejection.
    Smeesters C; Ehrlich RM; Fonkalsrud EW
    Am J Surg; 1976 May; 131(5):560-2. PubMed ID: 776011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
    Hultberg B; Ravnskov U
    Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urinary N-acetyl-beta-D-glucosaminidase activity in acute pyelonephritis patients with spinal cord injuries].
    Uozumi J; Iwatsubo E; Ando S; Hamano K; Hara S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jan; 80(1):54-8. PubMed ID: 2724745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
    Ekberg M; Hedner U; Larsson I; Nilsson IM; Nosslin B
    Scand J Clin Lab Invest; 1976 Sep; 36(5):453-9. PubMed ID: 790536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type I diabetes mellitus.
    Ellis EN; Brouhard BH; Lagrone L; Travis LB
    Diabetes Care; 1983; 6(3):251-5. PubMed ID: 6347577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC; Hockley M; Fenton SS; Wilson DR
    Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute response of urinary N-acetyl-beta-D-glucosaminidase to mannitol infusion in the dog.
    Brouhard BH; Lagrone L; Rowe J
    Am J Med Sci; 1985 Jul; 290(1):11-4. PubMed ID: 3929604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved kinetic rate assay of urinary N-acetyl-beta-D-glucosaminidase with 2-chloro-4-nitrophenyl-N-acetyl-beta-D-glucosaminide as substrate.
    Makise J; Saito E; Obuchi M; Kanayama M; Harakawa K; Yoshida K
    Clin Chem; 1990 Feb; 36(2):319-22. PubMed ID: 2302775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.